Timing and Selection for Renal Revascularization in an Era of Negative Trials: What to Do?

Progress in Cardiovascular Diseases

Volumn 52, Issue 3, 2009, Pages 220-228

  Textor, Stephen C ^a   McKusick, Michael M ^a   Misra, Sanjay ^a   Glockner, James ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ARTICLE; ATHEROSCLEROTIC RENAL ARTERY STENOSIS; CLINICAL RESEARCH; CLINICAL TRIAL; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOPPLER FLOWMETRY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY BLOOD FLOW; PATIENT SELECTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PLASMA RENIN ACTIVITY; RENOGRAPHY; RENOVASCULAR DISEASE; REVASCULARIZATION; RISK BENEFIT ANALYSIS; TISSUE OXYGENATION; TREATMENT PLANNING;

ANGIOPLASTY; ATHEROSCLEROSIS; CLINICAL TRIALS AS TOPIC; HUMANS; PATIENT SELECTION; RENAL ARTERY OBSTRUCTION; RENAL CIRCULATION; STENTS; TIME FACTORS; TREATMENT FAILURE;

EID: 71549123785     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcad.2009.10.001     Document Type: Article

References (49)

1. Textor S.C. Atherosclerotic renal artery stenosis: overtreated, but underrated?. J Am Soc Nephrol 19 (2008) 656-659
2. White C.J. Open renal arteries are better than closed renal arteries. Catheter Cardiovasc Diagn 45 (1998) 9-10
3. Safian R.D., and Madder R.D. Refining the approach to renal artery revascularization. J Am Coll Cardiol Intv 2 (2009) 161-174
4. Balk E., Raman G., Chung M., et al. Effectiveness of management strategies for renal artery stenosis: a systematic review. Ann Intern Med 145 (2006) 901-912
5. Wheatley K., Kalra P.A., Moss J., et al. Lack of benefit of renal artery revascularization in atheroslerotic renovascular disease (ARVD) results of the ASTRAL Trial. J Am Soc Nephrol 47A (2008) 19
6. Uzzo R.G., Novick A.C., Goormastic M., et al. Medical versus surgical management of atherosclerotic renal artery stenosis. Transplant Proc 34 (2002) 723-725
7. Fatica R.A., Port F.K., and Young E.W. Incidence trends and mortality in end-stage renal disease attributed to renovascular disease in the United States. Am J Kidney Dis 37 (2001) 1184-1190
8. Hirsch A.T., Haskal Z.J., Hertzer N.R., et al. ACC/AHA Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery, Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task force on Practice Guidelines. J Vasc Interv Radiol 17 (2006) 1383-1397
9. Rocha-Singh K.J., Eisenhauer A.C., Textor S.C., et al. Atherosclerotic peripheral vascular disease symposium II: Intervention for renal artery disease. Circulation 118 (2008) 2873-2878
10. Levin A., Linas S.L., Luft F.C., et al. Controversies in renal artery stenosis: a review by the American Society of Nephrology Advisory Group on Hypertension. Am J Nephrol 27 (2007) 212-220
11. Textor S.C., and Lerman L.O. Renal artery disease: pathophysiology. In: Creager M.A., Dzau V.J., and Loscalzo J. (Eds). Vascular medicine: a companion to Braunwald's heart disease (2006), Saunders-Elsevier, Philadelphia 323-334
12. De Bruyne B., Manoharan G., Pijls N.H.J., et al. Assessment of renal artery stenosis severity by pressure gradient measurements. J Am Coll Cardiol 48 (2006) 1851-1855
13. Simon G. What is critical renal artery stenosis? Implications for treatment. Am J Hyper 13 (2000) 1189-1193
14. Bax L., Woittiez A.J., Kouwenberg H.J., et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function. Ann Int Med 150 (2009) 999
15. Fisher J.E.E., and Olin J.W. Renal artery stenosis: clinical evaluation. In: Creager M.A., and Loscalzo J. (Eds). Vascular medicine: a companion to Braunwald's heart disease (2006), Saunders/Elsevier, Philadelphia 335-347
16. Stamey T.A., Nudelman J.J., Good P.H., et al. Functional characteristics of renovascular hypertension. Medicine 40 (1961) 347-394
17. Palmer J.M. Prognostic value of contralateral renal plasma flow in renovascular hypertension. JAMA 217 (1971) 794-802
18. Basso N., and Terragno N.A. History about the discovery of the renin-angiotensin system. Hypertension 38 (2001) 1246-1249
19. Juncos L.I., Strong C.G., and Hunt J.C. Prediction of results of surgery for renal and renovascular hypertension. Arch Int Med 134 (1974) 655-660
20. Vaughan E.D., Case D.B., Pickering T.G., et al. Indication for intervention in patients with renovascular hypertension. Am J Kidney Dis 5 (1985) A136-A143
21. Brunner H.R., Gavras H., and Laragh J.H. Specific inhibition of the renin-angiotensin system: A key to understanding blood pressure regulation. Prog Cardiovasc Dis 17 (1974) 87-98
22. Strong C.G., Hunt J.C., Sheps S.G., et al. Renal venous renin activity: enhancement of sensitivity of lateralization by sodium depletion. Am J Cardiol 27 (1971) 602-611
23. Gill-Leertouwer T.C., Gussenhoven E.J., Bosch J.L., et al. Predictors for clinical success at one year following renal artery stent placement. J Endovasc Ther 9 (2002) 495-502
24. Postma C.T., van Oijen A.H., Barentsz J.O., et al. The value of tests predicting renovascular hypertension in patients with renal artery stenosis treated by angioplasty. Arch Int Med 151 (1991) 1531-1535
25. Gerber L.M., Mann S.J., Muller F.B., et al. Response to the captopril test is dependent on baseline renin profile. J Hypertension 12 (1994) 173-178
26. Grim C.E., and Weinberger M.H. Diagnosis of renovascular hypertension: the case for renin assays. In: Narins R.G. (Ed). Controversies in Nephrology and Hypertension (1984), Churchill Livingstone, New York 109-122
27. Kane G.C., Textor S.C., Schirger A., et al. Revisiting the role of nephrectomy for advanced renovascular disease. Am J Med 114 (2003) 729-735
28. Vaughan Jr. E.D., Buhler F.R., Laragh J.H., et al. Renovascular hypertension: renin measurements to indicate hypersecretion and contralateral suppression, estimate renal plasma flow and score for surgery. Am J Med 55 (1973) 402-414
29. Safian R.D., and Textor S.C. Medical progress: renal artery stenosis. N Engl J Med. 344 (2001) 431-442
30. Lerman L.O., Nath K.A., Rodriguez-Porcel M., et al. Increased oxidative stress in experimental renovascular hypertension. Hypertension 37 (2001) 541-546
31. Geyskes G., Oei H.Y., Puylaert C.B., et al. Renovascular hypertension identified by captopril-induced changes in the renogram. Hypertension 9 (1987) 451-458
32. Elliot W.J., Martin W.B., and Murphy M.B. Comparison of two non-invasive screening tests for renovascular hypertension. Arch Intern Med 153 (1993) 755-764
33. Setaro J.F., Saddler M.C., Chen C.C., et al. Simplified captopril renography in diagnosis and treatment of renal artery stenosis. Hypertension 18 (1991) 289-298 Ref Type: Generic
34. Nally J.V., Chen C., Fine E., et al. Diagnostic criteria of renovascular hypertension with captopril renography: a consensus statement. Am J Hyper 4 12 Pt 2 (1991) 749s-752s
35. Taylor A. Functional testing: ACEI Renography. Semin Nephrol 20 (2000) 437-444
36. van Jaarsveld B.C., Krijnen P., Derkx F.H.M., et al. The place of renal scintigraphy in the diagnosis of renal artery stenosis. Arch Intern Med 157 (1997) 1226-1234
37. Picciotto G., Sargiotto A., Petrarulo M., et al. Reliability of captopril renography in patients under chronic therapy with angiotensin II (AT1) receptor antagonists. J Nucl Med 44 (2003) 1574-1581
38. Ludwig V., Martin W.H., and Delbeke D. Calcium channel blockers: a potential cause of false-positive captopril renography. Clin Nucl Med 28 (2003) 108-112
39. Li L., Vu A.T., Li B.S.Y., et al. Evaluation of intrarenal oxygenation by BOLD MRI at 3.0 T. J Magn Reson Imaging 20 (2004) 901-904
40. Prasad P.V., and Priatna A. Functional imaging of the kidneys with fast MRI techniques. Eur J Radiol 29 (1999) 133-148
41. Juillard L., Lerman L.O., Kruger D.G., et al. Blood oxygen level-dependent measurement of acute intra-renal ischemia. Kidney Int 65 (2004) 944-950
42. Textor S.C., Glockner J.F., Lerman L.O., et al. The use of magnetic resonance to evaluate tissue oxygenation in renal artery stenosis. J Am Soc Nephrol 19 (2008) 780-788
43. Djamali A., Sadowski E.A., Muehrer R.J., et al. BOLD-MRI assessment of intrarenal oxygenation and oxidative stress in patients with chronic kidney allograft dysfunction. Am J Physiol Renal Physiol 292 (2007) F513-F522
44. Textor S.C., Lerman L., and McKusick M. The uncertain value of renal artery interventions: where are we now?. J Am Coll Cardiol Cardiovasc Interv 2 (2009) 175-182
45. White C.J. Catheter-based therapy for atherosclerotic renal artery stenosis. Circulation 113 (2006) 1464-1473
46. Mistry S., Ives N., Harding J., et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. J Human Hyper (2007) advance online (March 2007)
47. Losito A., Gaburri M., Errico R., et al. Survival of patients with renovascular disease and ACE inhibition. Clin Nephrol 52 (1999) 339-343
48. Hackam D.G., Duong-Hua M.L., Mamdani M., et al. Angiotensin inhibition in renovascular disease: a population-based cohort study. Am Heart J 156 (2008) 549-555
49. Murphy T.P., Cooper C.J., Dworkin L.D., et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) Study: Rationale and Methods. J Vasc Interv Radiol 16 (2005) 1295-1300